Tags

Type your tag names separated by a space and hit enter

Posterior fossa decompression and duraplasty with and without tonsillar resection for the treatment of adult Chiari malformation type I and syringomyelia.
Medicine (Baltimore). 2022 Dec 16; 101(50):e31394.M

Abstract

BACKGROUND

The current surgical management of adult Chiari malformation type I (CM-I) with associated syringomyelia remains controversial. The objective of this study was to explore posterior fossa decompression and duraplasty (PFDD) with and without tonsillar resection in adult patients with CM-I and syringomyelia.

METHODS

A total of 116 adult patients suffering from both CM-I and syringomyelia who were scheduled to undergo surgical decompression at our institution between 2012 and 2020 were randomly divided into 2 groups: the PFDD group (n = 64) underwent PFDD without tonsillar resection, while the PFDD-T group (n = 52) underwent PFDD with tonsillar resection. The primary outcome was improvement or resolution of the syrinx. The secondary outcome was an improvement in clinical outcome based on Chicago Chiari Outcome Scale (CCOS) scores. All participants were followed-up to 1-year postoperatively.

RESULTS

The proportions of patients who had >20% improvement in syrinx size were 60.9% and 78.8% in the PFDD and PFDD-T groups, respectively (P = .038). The improvement in clinical outcome based on CCOS scores was significantly different in the 2 groups (P = .004). The functionality sub-score was significantly different between the 2 groups (P = .027), but there were no significant differences in the pain symptoms, non-pain symptoms, and complications sub-scores. The total CCOS scores were higher in the PFDD-T group than in the PFDD group (P = .037).

CONCLUSION

This study determined the role of tonsillar resection in achieving obvious syrinx improvement following PFDD-T. PFDD with tonsillar resection seems to be a safe and effective surgical option to treat adult CM-I patients with syringomyelia.

Authors+Show Affiliations

Fourth Neurosurgery Department, Cangzhou Central Hospital, Cangzhou, Hebei Province, PR China.No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Randomized Controlled Trial
Journal Article

Language

eng

PubMed ID

36550873

Citation

Yang, Ming, et al. "Posterior Fossa Decompression and Duraplasty With and Without Tonsillar Resection for the Treatment of Adult Chiari Malformation Type I and Syringomyelia." Medicine, vol. 101, no. 50, 2022, pp. e31394.
Yang M, Niu HT, Jiang HS, et al. Posterior fossa decompression and duraplasty with and without tonsillar resection for the treatment of adult Chiari malformation type I and syringomyelia. Medicine (Baltimore). 2022;101(50):e31394.
Yang, M., Niu, H. T., Jiang, H. S., & Wang, Y. Z. (2022). Posterior fossa decompression and duraplasty with and without tonsillar resection for the treatment of adult Chiari malformation type I and syringomyelia. Medicine, 101(50), e31394. https://doi.org/10.1097/MD.0000000000031394
Yang M, et al. Posterior Fossa Decompression and Duraplasty With and Without Tonsillar Resection for the Treatment of Adult Chiari Malformation Type I and Syringomyelia. Medicine (Baltimore). 2022 Dec 16;101(50):e31394. PubMed PMID: 36550873.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Posterior fossa decompression and duraplasty with and without tonsillar resection for the treatment of adult Chiari malformation type I and syringomyelia. AU - Yang,Ming, AU - Niu,Hai-Tao, AU - Jiang,Hong-Sheng, AU - Wang,Yan-Zhou, PY - 2022/12/23/entrez PY - 2022/12/24/pubmed PY - 2022/12/27/medline SP - e31394 EP - e31394 JF - Medicine JO - Medicine (Baltimore) VL - 101 IS - 50 N2 - BACKGROUND: The current surgical management of adult Chiari malformation type I (CM-I) with associated syringomyelia remains controversial. The objective of this study was to explore posterior fossa decompression and duraplasty (PFDD) with and without tonsillar resection in adult patients with CM-I and syringomyelia. METHODS: A total of 116 adult patients suffering from both CM-I and syringomyelia who were scheduled to undergo surgical decompression at our institution between 2012 and 2020 were randomly divided into 2 groups: the PFDD group (n = 64) underwent PFDD without tonsillar resection, while the PFDD-T group (n = 52) underwent PFDD with tonsillar resection. The primary outcome was improvement or resolution of the syrinx. The secondary outcome was an improvement in clinical outcome based on Chicago Chiari Outcome Scale (CCOS) scores. All participants were followed-up to 1-year postoperatively. RESULTS: The proportions of patients who had >20% improvement in syrinx size were 60.9% and 78.8% in the PFDD and PFDD-T groups, respectively (P = .038). The improvement in clinical outcome based on CCOS scores was significantly different in the 2 groups (P = .004). The functionality sub-score was significantly different between the 2 groups (P = .027), but there were no significant differences in the pain symptoms, non-pain symptoms, and complications sub-scores. The total CCOS scores were higher in the PFDD-T group than in the PFDD group (P = .037). CONCLUSION: This study determined the role of tonsillar resection in achieving obvious syrinx improvement following PFDD-T. PFDD with tonsillar resection seems to be a safe and effective surgical option to treat adult CM-I patients with syringomyelia. SN - 1536-5964 UR - https://www.unboundmedicine.com/medline/citation/36550873/Posterior_fossa_decompression_and_duraplasty_with_and_without_tonsillar_resection_for_the_treatment_of_adult_Chiari_malformation_type_I_and_syringomyelia_ DB - PRIME DP - Unbound Medicine ER -